Access the full text.
Sign up today, get DeepDyve free for 14 days.
CC Chang (2011)
27ACM Trans Intell Syst Technol, 2
M Sakakibara (2010)
An empirical analysis of pricing in patent licensing contractsInd Corp Chang, 19
A Salazar, R Hackney, J Howells (2003)
The strategic impact of internet technology in biotechnology and pharmaceutical firms: insights from a knowledge management perspectiveInfo Technol Manag, 4
J Racine (2006)
133J Appl Econ, 21
CC Chang, CJ Lin (2011)
LIBSVM: a library for support vector machinesACM Trans Intell Syst Technol, 2
R Henderson, AB Jaffe, M Trajtenberg (1988)
Universities as a source of commercial technology: a detailed analysis of university patenting, 1965–1988Rev Econ Stat, 80
F Pedregosa, G Varoquaux, A Gramfort, V Michel, B Thirion, O Grisel (2011)
Scikit-learn: machine learning in PythonJ Mach Learn Res, 12
D Butler (2008)
840Nature News, 453
JM Fernandez (2012)
964Nat Biotechnol, 30
Y Zhang, Y Yang, H Zhang, X Jiang, B Xu, Y Xue, Y Cao, Q Zhai, Y Zhai, M Xu, HJ Cooke, Q Shi (2011)
Prediction of novel pre-microRNAs with high accuracy through boosting and SVMBioinformatics, 27
K Ruckman, I McCarthy (2017)
Why do some patents get licensed while others do not?Ind Corp Change., 26
MI Leone, T Reichstein (2012)
Licensing-in fosters rapid invention! The effect of the grant-back clause and technological unfamiliarityStrat Mgmt J, 33
K Laursen, MI Leone, S Torrisi (2010)
Technological exploration through licensing: new insights from the licensee’s point of viewInd Corp Change, 19
T Oliphant, TE SciPy (2007)
Open source scientific tools for PythonComput Sci Eng, 9
D Butler (2008)
Translational research: crossing the valley of deathNature News, 453
K Ruckman (2017)
667Ind Corp Change., 26
VN Vapnik (1999)
An overview of statistical learning theoryIEEE Trans Neural Netw, 10
PF Pai, WC Hong, PT Change, CT Chen (2006)
The application of support vector machines to forecast tourist arrivals in Barbados: an empirical studyInt J Manag, 23
SVD Walt, SC Colbert, G Varoquaux (2011)
The NumPy array: a structure for efficient numerical computationComput Sci Eng, 13
J Racine (2006)
Gnuplot 4.0: a portable interactive plotting utilityJ Appl Econ, 21
CY Tseng, MS Chen (2009)
Incremental SVM model for spam detection on dynamic email social networksIEEE CSE Int Conf, 4
P Neuhäusler, R Frietsch (2013)
Patent families as macro level patent value indicators: applying weights to account for market differencesScientometrics, 96
DM Powers (2011)
Evaluation: from precision, recall and F-measure to ROC, 2011 informedness, markedness and correlationJ Mach Learn Tech, 2
S Hua, Z Sun (2001)
Support vector machine approach for protein subcellular localization predictionBioinformatics, 17
Y Zhang (2011)
1436Bioinformatics, 27
SVD Walt (2011)
22Comput Sci Eng, 13
R Henderson (1988)
119Rev Econ Stat, 80
F Pedregosa (2011)
2825J Mach Learn Res, 12
CS Yu, CJ Lin, JK Hwang (2004)
Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n-peptide compositionsProtein Sci, 13
JM Fernandez, RM Stein, AW Lo (2012)
Commercializing biomedical research through securitization techniquesNat Biotechnol, 30
VN Vapnik (1999)
988IEEE Trans Neural Netw, 10
J Ni, R Shao, COL Ung, Y Wang, Y Hu, Y Cai (2015)
Valuation of pharmaceutical patents: a comprehensive analytical framework based on technological, commercial, and legal factorsJ Pharm Innov, 10
TC Campos (2015)
The idea of patents vs. the idea of universityNew Bioethnol, 21
T Oliphant (2007)
10Comput Sci Eng, 9
J Ni (2015)
281J Pharm Innov, 10
Purpose Pharmaceutical technology transfer is one of the components of pharmaceutical innovation. Currently, a gap exists in pharmaceutical technology transfer from academia to industry. This study aims to develop an objective model to identify valuable pharmaceutical technologies for transferring in order to drive pharmaceutical innovation. Methods We created a support vector machine classifier model using the data of pharmaceutical patents held by universities to predict the licensing outcomes of those patents. We collected data on 369 United States (US) pharmaceutical patents, using 142 licensed patents as the positive samples and 227 unlicensed patents as the negative samples. We also collected the licensing data of the patents, and the distinguished patent features were selected for model training and generation. Upon optimization, the machine learning model was evaluated using different scoring methods. Results Our support vector machine-based model achieved a fairly good performance of 82.50% in precision and 88.89% in specificity. Conclusions To the best of our knowledge, our study is the first to apply the machine learning approach to predict the licensing outcomes for pharmaceutical patent valuation and technology transfer. Our work is a good alternative to the current patent valuation methods available in the market, and it could be
Journal of Pharmaceutical Innovation – Springer Journals
Published: Jun 2, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.